Effect of MIST on Esophageal Sensitivity: Pilot Study
PilotMIST
Ffect of Acute Psychosocial Stress on Esophageal Sensitivity in Patients With Refractory Gastro-esophageal Reflux Disease and Healthy Volunteers
1 other identifier
observational
15
1 country
1
Brief Summary
Influence of placing the esophageal probe on the cortisol response. Number of cortisol (non)responders and association of heart rate and subjective perception of stress with cortisol levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2021
CompletedStudy Start
First participant enrolled
November 4, 2021
CompletedFirst Posted
Study publicly available on registry
March 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedMarch 8, 2023
March 1, 2023
1.7 years
October 20, 2021
March 6, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
cortisol levels
Change in cortisol levels
every 15 minutes a saliva sample during 4.5 hours: at time points (in minutes) 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 195, 210, 225, 240, 255, 270
Secondary Outcomes (1)
cortisol responders
up to 4 hours of cortisol measurement
Study Arms (1)
Placement of an esophageal catheter
In this group we will assess the influence of placing an esophageal catheter on the cortisol levels in HV
Interventions
Placing an esophageal probe through the mouth
Eligibility Criteria
Healthy volunteers with no or less experience with placing an esophageal probe
You may qualify if:
- Aged between 18 to 65 years. All participants will receive and sign a copy of the informed consent before initiation of the study.
You may not qualify if:
- A history of any upper gastrointestinal (GI) symptoms, complaints or diseases;
- Prior history of esophageal or gastric surgery or endoscopic anti-reflux procedure;
- Psychiatric disorders;
- Concomitant use of other medication or treatments except for oral contraceptives;
- Use of medication altering GI motility;
- Pregnant or nursing women;
- History of drugs or alcohol abuse.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
TARGID
Leuven, Vlaams-Brabant, Belgium
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
October 20, 2021
First Posted
March 8, 2023
Study Start
November 4, 2021
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
March 8, 2023
Record last verified: 2023-03